| LncRNA |
Compound |
Cancer |
P-value |
Effect |
| ENSG00000230082.1 |
Gefitinib |
Head and neck squamous cell carcinoma |
0.02309875 |
Resistant |
| ENSG00000230082.1 |
Gefitinib |
Kidney renal clear cell carcinoma |
0.013658002 |
Resistant |
| ENSG00000230082.1 |
Gefitinib |
Thyroid carcinoma |
0.024542368 |
Resistant |
